top of page
NEWS & INSIGHTS
Dive into the Biopharma Space
Stay up-to-date on major biopharma news, deeper dives into specific companies and biopharma themes, and how it all relates to biopharma partners.
FEATURED POST


🎯 How to Find and Export Contacts in BiopharmIQ: A Step-by-Step Guide for Sales & Marketing Teams
BiopharmIQ is designed to empower sales and marketing professionals in the life sciences industry with targeted lists of companies and...

BiopharmIQ


10 Bio/Pharma Companies to Watch in Seattle - 2025
Seattle continues to make waves in the life sciences arena, blending the city’s deep research heritage with a new generation of biotech innovation. From next-generation antibody-drug conjugates to advanced RNA vaccines, the Emerald City is home to companies pushing the boundaries of how we diagnose, treat, and understand disease. Here are 10 companies to watch in 2025 , each driving fresh breakthroughs through clinical success, funding momentum, or technological innovation.
4 days ago


10 Antibody Companies to Watch in Southern California - 2025
Southern California has long been known for its beaches and biotech, and nowhere is the region’s innovation more evident than in its antibody ecosystem . From San Diego’s wet labs to Pasadena’s protein engineers , the area has become a proving ground for companies blending creativity, capital, and clinical progress. At BiopharmIQ, we’ve tracked more than a hundred SoCal bio/pharma's developing antibody-based drugs, and we’ve handpicked 10 companies to watch in 2025 , chosen
Oct 29


2025 Bio/Pharma Funding Trends: September’s Update
" Private bio/pharma funding activity strengthened in September, reaching its highest level since early 2025 and reflecting a gradual re-acceleration in deal flow. " September 2025 marks the end of the third quarter with a significant uptick in deal activity , even though total dollars raised remain below early-year highs. The market continues to favor non-dilutive funding and smaller financings, with grants leading by deal count and early-stage rounds bouncing back from th
Oct 23


10 Bio/Pharma Companies to Watch in Texas - 2025
At BiopharmIQ , we’ve mapped over 280 biotech and pharma companies in Texas, tracking the rapid evolution of one of the most dynamic innovation hubs in the U.S. What once was a regional life sciences cluster is now a full-fledged ecosystem, where emerging bio/pharmas, mid-sized innovators, and major pharmaceutical players converge. This year’s landscape highlights clinical-stage activity, late preclinical acceleration, and significant capital infusions across therapeutic are
Oct 14


10 Radiopharma Companies to Watch
Radiopharmaceuticals are rapidly gaining attention across the biopharma industry, combining targeted delivery with therapeutic...
Sep 8


Cell Therapy Fundings (2025 YTD): Key Deals and Trends
Cell therapy continues to be one of the most dynamic segments of biotech and pharma financing in 2025. From oncology to neurology,...
Aug 29


Gene Editing Companies Landscape
Gene editing has emerged as one of the most transformative technologies in biotech and pharma, with applications spanning therapeutics,...
Apr 3


Annual 2024 Funding Report: Early & Late Stage Bio/Pharma Funding Over $1M
The global biotech and pharmaceutical landscape in 2024 continued to attract significant investment, with our BiopharmIQ system capturing...
Feb 19


December 2024 Early & Late-Stage >$1M Funded Bio/Pharma Companies
Bio/pharma continued to attract investments in December 2024 to support the discovery and development of new bio/pharma therapeutics. In...
Jan 31


November 2024 Early & Late-Stage >$1M Funded Biotech Companies
We analyzed biotech funding data on our online biopharmIQ platform to identify companies who had early-stage (Angel/Pre-Seed, Seed,...
Dec 30, 2024


AI in Bio/Pharma Technology Development
There is a lot that has been published about the possible impact of AI on healthcare and the development of new therapeutics. In fact,...
Nov 26, 2024


2024 Q1-Q3 Early Stage >$1M funded Biotech Companies
We analyzed biotech funding data on our online biopharmIQ platform to identify companies who had early-stage (Angel/Pre-Seed, Seed,...
Oct 2, 2024


New/Newly Emerging Biotech Companies (2024 ytd)
We used our our online biopharmIQ platform to analyze 2024 data (through September 9) on newly formed biotech companies and biotech...
Sep 12, 2024


Biotech $1M+ Early Round Funding Activity - 1st Half 2024
We analyzed biotech funding data on our online BiopharmIQ platform to identify companies that had early-stage (Angel/Pre-Seed, Seed,...
Aug 21, 2024


23 recently-funded U.S. clinical stage cancer companies: Target customers for you?
We used our powerful online clinical trial/sponsor search platform at BiopharmIQ.com to identify 23 small (250 employees or less),...
Aug 15, 2024


AAV and Lenti Vector Companies by Country
When it comes to cell and gene therapy, AAV and lenti vectors are by far the most common vectors. Check out our free list of AAV and...
Aug 6, 2024


Cell & Gene Tx Startups by State
Large bio/pharma companies have an ongoing need to fill their therapeutic product development funnels. To do this they often acquire...
Apr 24, 2024


San Diego Biotech Sector 2024
San Diego has a rich biotech ecosystem. From startups and small to mid-cap companies to major and well-established players. According to...
Apr 19, 2024


Cell & Gene Tx Companies in BioCapital Region
The BioCapital region is a hub for biotechnology innovation, with significant growth in the past few decades. Within the groundbreaking...
Mar 13, 2024


Cell Therapy Spotlight: Pharm Country esp. Philadelphia: Is Pharm Country Becoming Cell Therapy Country?
When it comes to Pharm Country (NY, NJ, PA, CT, and RI), Pennsylvania is a hotbed for cell therapy (FIG. 1 📸). We found 39 companies in...
Feb 6, 2024
Please fill out the following information along with your message.
bottom of page